Phase
Condition
Autism
Williams Syndrome
Asperger's Disorder
Treatment
N/AClinical Study ID
Ages 3-17 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Be between the ages of 3 years 0 months and 17 years 11 months at the time ofrandomization
- Be diagnosed by clinician experienced in assessment of ASD with autistic disorder,Asperger's syndrome, or PDD-NOS using DSM-V-TR criteria
- Must have clinical diagnosis of ASD confirmed using the Autism Diagnostic ObservationScale (ADOS, Lord et al., 2001)
- Must have clinical diagnosis of ASD confirmed using the Autism DiagnosticInterview-Revised (ADI-R, Rutter, 2003). ASD criteria proposed by Risi (2006).Specifically, subject must be within 1 point of autism criteria on both social andcommunication domains of the ADI or meet autism criteria in one of these ADI domainsand come within 2 points of autism criteria in the other
- Have a guardian who is able to provide informed consent
- If cognitively able, subject must be able to provide informed assent/consent
Exclusion
Exclusion Criteria:
- Have a known diagnosis of Rett Syndrome or Childhood Disintegrative Disorder, or havemarked sensory impairment such as deafness or blindness
- Have active cardiovascular disease or renal disease that is not controlled bymedication
- Subjects who are pregnant, lactating, or who refuse to practice contraception ifsexually active
- Subjects who have had changes in allied health therapies, behavioral or educationalinterventions within the two months prior to randomization other than those associatedwith school holidays
- Subjects who have had changes in psychiatric medications within 4 weeks ofrandomization
- Subjects who have had previous chronic treatment with oxytocin
- Subjects who have caretakers who are unable to speak English, be consistently presentat visits to report on symptoms, or are otherwise judged as unable to comply with theprotocol by the data collection site team
- Subjects with active seizures within the 6 months preceding screening or baseline -added part way through study in response to subject death.
Study Design
Study Description
Connect with a study center
Lurie Center for Autism, Massachusetts General Hospital
Boston, Massachusetts 02114
United StatesSite Not Available
Mount Sinai School of Medicine
New York, New York 10029
United StatesSite Not Available
Center for Autism and the Developing Brain
White Plains, New York 10605
United StatesSite Not Available
The University of North Carolina at Chapel Hill, Department of Psychiatry
Chapel Hill, North Carolina 27517
United StatesSite Not Available
Duke Center for Autism and Brain Development
Durham, North Carolina 27705
United StatesSite Not Available
Duke University , Genetics Center
Durham, North Carolina 27710
United StatesSite Not Available
Vanderbilt University
Nashville, Tennessee 37212
United StatesSite Not Available
Seattle Children's Hospital Research Institute
Seattle, Washington 98105
United StatesSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.